Computationally driven discovery of SARS-CoV-2 Mpro inhibitors: from design to experimental validation
Authors:
L. El Khoury,
Z. **g,
A. Cuzzolin,
A. Deplano,
D. Loco,
B. Sattarov,
F. Hédin,
S. Wendeborn,
C. Ho,
D. El Ahdab,
T. Jaffrelot Inizan,
M. Sturlese,
A. Sosic,
M. Volpiana,
A. Lugato,
M. Barone,
B. Gatto,
M. Ludovica Macchia,
M. Bellanda,
R. Battistutta,
C. Salata,
I. Kondratov,
R. Iminov,
A. Khairulin,
Y. Mykhalonok
, et al. (10 additional authors not shown)
Abstract:
We report a fast-track computationally-driven discovery of new SARS-CoV2 Main Protease (M$^{pro}$) inhibitors whose potency range from mM for initial non-covalent ligands to sub-$μ$M for the final covalent compound (IC50=830 +/- 50 nM). The project extensively relied on high-resolution all-atom molecular dynamics simulations and absolute binding free energy calculations performed using the polariz…
▽ More
We report a fast-track computationally-driven discovery of new SARS-CoV2 Main Protease (M$^{pro}$) inhibitors whose potency range from mM for initial non-covalent ligands to sub-$μ$M for the final covalent compound (IC50=830 +/- 50 nM). The project extensively relied on high-resolution all-atom molecular dynamics simulations and absolute binding free energy calculations performed using the polarizable AMOEBA force field. The study is complemented by extensive adaptive sampling simulations that are used to rationalize the different ligands binding poses through the explicit reconstruction of the ligand-protein conformation spaces. Machine Learning predictions are also performed to predict selected compound properties. While simulations extensively use High Performance Computing to strongly reduce time-to-solution, they were systematically coupled to Nuclear Magnetic Resonance experiments to drive synthesis and to in vitro characterization of compounds. Such study highlights the power of in silico strategies that rely on structure-based approaches for drug design and allows to address the protein conformational multiplicity problem. The proposed fluorinated tetrahydroquinolines open routes for further optimization of M$^{pro}$ inhibitors towards low nM affinities.
△ Less
Submitted 24 January, 2022; v1 submitted 11 October, 2021;
originally announced October 2021.
SkeleDock: A Web Application for Scaffold Docking in PlayMolecule
Authors:
Alejandro Varela-Rial,
Maciej Majewski,
Alberto Cuzzolin,
Gerard Martínez-Rosell,
Gianni De Fabritiis
Abstract:
SkeleDock is a scaffold docking algorithm which uses the structure of a protein-ligand complex as a template to model the binding mode of a chemically similar system. This algorithm was evaluated in the D3R Grand Challenge 4 pose prediction challenge, where it achieved competitive performance. Furthermore, we show that, if crystallized fragments of the target ligand are available, SkeleDock can ou…
▽ More
SkeleDock is a scaffold docking algorithm which uses the structure of a protein-ligand complex as a template to model the binding mode of a chemically similar system. This algorithm was evaluated in the D3R Grand Challenge 4 pose prediction challenge, where it achieved competitive performance. Furthermore, we show that, if crystallized fragments of the target ligand are available, SkeleDock can outperform rDock docking software at predicting the binding mode. This article also addresses the capacity of this algorithm to model macrocycles and deal with scaffold hop**. SkeleDock can be accessed at https://playmolecule.org/SkeleDock/.
△ Less
Submitted 12 May, 2020;
originally announced May 2020.
